CNB Bank’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.25M | Hold |
44,385
| – | – | 0.52% | 45 |
|
|
2025
Q4 | $1.11M | Sell |
44,385
-493
| -1% | -$12.4K | 0.45% | 54 |
|
|
2025
Q3 | $1.14M | Buy |
44,878
+5,418
| +14% | +$134K | 0.48% | 48 |
|
|
2025
Q2 | $957K | Sell |
39,460
-1,214
| -3% | -$28.3K | 0.45% | 54 |
|
|
2025
Q1 | $1.03M | Sell |
40,674
-2,870
| -7% | -$75.1K | 0.52% | 51 |
|
|
2024
Q4 | $1.16M | Sell |
43,544
-3,701
| -8% | -$100K | 0.54% | 45 |
|
|
2024
Q3 | $1.37M | Sell |
47,245
-1,714
| -4% | -$50K | 0.63% | 36 |
|
|
2024
Q2 | $1.37M | Sell |
48,959
-4,545
| -8% | -$125K | 0.66% | 35 |
|
|
2024
Q1 | $1.48M | Sell |
53,504
-14,375
| -21% | -$399K | 0.72% | 37 |
|
|
2023
Q4 | $1.95M | Sell |
67,879
-1,079
| -2% | -$32.6K | 1.05% | 21 |
|
|
2023
Q3 | $2.29M | Sell |
68,958
-472
| -0.7% | -$16.7K | 1.35% | 15 |
|
|
2023
Q2 | $2.55M | Sell |
69,430
-1,601
| -2% | -$62.3K | 1.5% | 13 |
|
|
2023
Q1 | $2.9M | Sell |
71,031
-75
| -0.1% | -$3.24K | 1.76% | 9 |
|
|
2022
Q4 | $3.64M | Buy |
71,106
+296
| +0.4% | +$14.2K | 2.28% | 6 |
|
|
2022
Q3 | $3.1M | Sell |
70,810
-250
| -0.4% | -$12.1K | 2.1% | 6 |
|
|
2022
Q2 | $3.73M | Buy |
71,060
+2,251
| +3% | +$115K | 2.41% | 6 |
|
|
2022
Q1 | $3.56M | Sell |
68,809
-724
| -1% | -$37.6K | 2% | 7 |
|
|
2021
Q4 | $4.11M | Sell |
69,533
-1,304
| -2% | -$64.6K | 2.25% | 7 |
|
|
2021
Q3 | $3.05M | Buy |
70,837
+1,554
| +2% | +$68.8K | 1.83% | 8 |
|
|
2021
Q2 | $2.71M | Buy |
69,283
+82
| +0.1% | +$3.19K | 1.7% | 8 |
|
|
2021
Q1 | $2.51M | Sell |
69,201
-1,814
| -3% | -$64.4K | 1.73% | 8 |
|
|
2020
Q4 | $2.61M | Sell |
71,015
-6,700
| -9% | -$246K | 1.97% | 8 |
|
|
2020
Q3 | $2.71M | Buy |
77,715
+1,539
| +2% | +$54K | 2.28% | 8 |
|
|
2020
Q2 | $2.36M | Sell |
76,176
-325
| -0.4% | -$11K | 2.08% | 6 |
|
|
2020
Q1 | $2.37M | Buy |
76,501
+1,016
| +1% | +$34.6K | 2.55% | 4 |
|
|
2019
Q4 | $2.81M | Buy |
75,485
+2,885
| +4% | +$103K | 2.38% | 4 |
|
|
2019
Q3 | $2.48M | Buy |
72,600
+2,152
| +3% | +$78.3K | 2.29% | 4 |
|
|
2019
Q2 | $2.9M | Buy |
70,448
+735
| +1% | +$29.2K | 2.47% | 5 |
|
|
2019
Q1 | $2.81M | Buy |
69,713
+8,180
| +13% | +$328K | 1.45% | 11 |
|
|
2018
Q4 | $2.55M | Sell |
61,533
-1,510
| -2% | -$62.7K | 1.62% | 10 |
|
|
2018
Q3 | $2.64M | Sell |
63,043
-869
| -1% | -$33.5K | 1.51% | 9 |
|
|
2018
Q2 | $2.2M | Buy |
63,912
+100
| +0.2% | +$3.42K | 1.28% | 12 |
|
|
2018
Q1 | $2.15M | Buy |
63,812
+3,966
| +7% | +$136K | 1.26% | 13 |
|
|
2017
Q4 | $2.06M | Buy |
+59,846
| New | +$2.04M | 1.23% | 14 |
|
Other funds holding PFE
VCM
VPM
CNB Bank's PFE Position: Q1 2026 in Review
CNB Bank held its Pfizer (PFE) position steady in Q1 2026 at 44,385 shares worth $1.25M. The position accounts for 0.52% of the portfolio, ranked #45.
CNB Bank first reported a position in PFE in Q4 2017 and has held it in 34 quarters since. The position peaked at $4.11M in Q4 2021. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- CNB Bank held 44,385 shares of Pfizer worth $1.25M as of Q1 2026.
- CNB Bank left its Pfizer share count unchanged in Q1 2026.
- Pfizer made up 0.52% of CNB Bank's portfolio in Q1 2026, its #45 holding.
- CNB Bank first reported a position in Pfizer in Q4 2017 and has held it in 34 quarters since.
- CNB Bank's Pfizer position peaked at $4.11M in Q4 2021.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on CNB Bank's 13F filing for Q1 2026, filed 6 May 2026.